MXPA00001638A - Process for the fermentative production of l-amino acids using coryneform bacteria - Google Patents
Process for the fermentative production of l-amino acids using coryneform bacteriaInfo
- Publication number
- MXPA00001638A MXPA00001638A MXPA/A/2000/001638A MXPA00001638A MXPA00001638A MX PA00001638 A MXPA00001638 A MX PA00001638A MX PA00001638 A MXPA00001638 A MX PA00001638A MX PA00001638 A MXPA00001638 A MX PA00001638A
- Authority
- MX
- Mexico
- Prior art keywords
- amino acids
- bacteria
- glutamate
- fermentation
- plasmid vector
- Prior art date
Links
- 150000008575 L-amino acids Chemical class 0.000 title claims abstract description 32
- 241000186031 Corynebacteriaceae Species 0.000 title claims abstract description 9
- 238000000034 method Methods 0.000 title claims description 15
- 238000004519 manufacturing process Methods 0.000 title description 18
- 238000000855 fermentation Methods 0.000 claims abstract description 13
- 230000004151 fermentation Effects 0.000 claims abstract description 13
- 238000002360 preparation method Methods 0.000 claims abstract description 13
- 102000016901 Glutamate dehydrogenases Human genes 0.000 claims abstract description 11
- 108091000037 Glutamate dehydrogenases Proteins 0.000 claims abstract description 11
- 229920001850 Nucleic acid sequence Polymers 0.000 claims abstract description 6
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 21
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 18
- 241000186226 Corynebacterium glutamicum Species 0.000 claims description 16
- 241000894006 Bacteria Species 0.000 claims description 15
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 15
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 14
- 235000019766 L-Lysine Nutrition 0.000 claims description 10
- 239000004472 Lysine Substances 0.000 claims description 10
- 229960003646 lysine Drugs 0.000 claims description 10
- 235000001014 amino acid Nutrition 0.000 claims description 9
- 150000001413 amino acids Chemical class 0.000 claims description 9
- 229960004295 valine Drugs 0.000 claims description 9
- 229960000310 ISOLEUCINE Drugs 0.000 claims description 7
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 7
- 239000004473 Threonine Substances 0.000 claims description 7
- 229960002898 threonine Drugs 0.000 claims description 7
- 108010020056 Hydrogenase Proteins 0.000 claims description 6
- 229940024606 Amino Acids Drugs 0.000 claims description 4
- 229940021015 I.V. solution additive Amino Acids Drugs 0.000 claims description 4
- 101710006382 pek-1 Proteins 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 241000588724 Escherichia coli Species 0.000 claims description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 2
- BAWFJGJZGIEFAR-NNYOXOHSSA-N Nicotinamide adenine dinucleotide Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 claims description 2
- 229960002429 Proline Drugs 0.000 claims description 2
- ZKJOXOJMGXFSPF-QYZPTAICSA-N [[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate;hydrate Chemical compound O.NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 ZKJOXOJMGXFSPF-QYZPTAICSA-N 0.000 claims description 2
- 229950006238 nadide Drugs 0.000 claims description 2
- 238000005755 formation reaction Methods 0.000 claims 2
- 230000037353 metabolic pathway Effects 0.000 claims 2
- 239000002609 media Substances 0.000 description 28
- 244000005700 microbiome Species 0.000 description 12
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 8
- 230000000875 corresponding Effects 0.000 description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- 241000319304 [Brevibacterium] flavum Species 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- WQZGKKKJIJFFOK-VFUOTHLCSA-N β-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- BJHIKXHVCXFQLS-UYFOZJQFSA-N Fructose Natural products OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 4
- GUBGYTABKSRVRQ-YOLKTULGSA-N Maltose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)O[C@H]1CO)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 GUBGYTABKSRVRQ-YOLKTULGSA-N 0.000 description 4
- 229960004799 Tryptophan Drugs 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000001963 growth media Substances 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 230000003287 optical Effects 0.000 description 4
- 230000002018 overexpression Effects 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 229940041514 Candida albicans extract Drugs 0.000 description 3
- 241000186216 Corynebacterium Species 0.000 description 3
- UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine zwitterion Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 description 3
- 210000000214 Mouth Anatomy 0.000 description 3
- 241000192013 Peptoniphilus asaccharolyticus Species 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 229920003013 deoxyribonucleic acid Polymers 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- 230000002068 genetic Effects 0.000 description 3
- 238000004255 ion exchange chromatography Methods 0.000 description 3
- 229960000318 kanamycin Drugs 0.000 description 3
- OOYGSFOGFJDDHP-KMCOLRRFSA-N kanamycin A sulfate Chemical compound OS(O)(=O)=O.O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N OOYGSFOGFJDDHP-KMCOLRRFSA-N 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- -1 phosphoribosyl Chemical group 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- 229960003767 Alanine Drugs 0.000 description 2
- 241001485655 Corynebacterium glutamicum ATCC 13032 Species 0.000 description 2
- 241000133018 Corynebacterium melassecola Species 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N Kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229960002064 Kanamycin Sulfate Drugs 0.000 description 2
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- GUBGYTABKSRVRQ-UUNJERMWSA-N Lactose Natural products O([C@@H]1[C@H](O)[C@H](O)[C@H](O)O[C@@H]1CO)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 GUBGYTABKSRVRQ-UUNJERMWSA-N 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N Linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N Palmitic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 210000004027 cells Anatomy 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000001419 dependent Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002255 enzymatic Effects 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L mgso4 Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000005020 pharmaceutical industry Methods 0.000 description 2
- 230000001105 regulatory Effects 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 229920000160 (ribonucleotides)n+m Polymers 0.000 description 1
- 229940100197 ANTIMETABOLITES Drugs 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- PRKQVKDSMLBJBJ-UHFFFAOYSA-N Ammonium carbonate Chemical compound N.N.OC(O)=O PRKQVKDSMLBJBJ-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- DVARTQFDIMZBAA-UHFFFAOYSA-O Ammonium nitrate Chemical compound [NH4+].[O-][N+]([O-])=O DVARTQFDIMZBAA-UHFFFAOYSA-O 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N Ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229940064005 Antibiotic throat preparations Drugs 0.000 description 1
- 229940083879 Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Drugs 0.000 description 1
- 229940042052 Antibiotics for systemic use Drugs 0.000 description 1
- 229940019746 Antifibrinolytic amino acids Drugs 0.000 description 1
- 229940042786 Antitubercular Antibiotics Drugs 0.000 description 1
- 210000000349 Chromosomes Anatomy 0.000 description 1
- 241001517047 Corynebacterium acetoacidophilum Species 0.000 description 1
- 241000337023 Corynebacterium thermoaminogenes Species 0.000 description 1
- 108010064711 EC 1.1.1.3 Proteins 0.000 description 1
- 108010000700 EC 2.2.1.6 Proteins 0.000 description 1
- 241001646716 Escherichia coli K-12 Species 0.000 description 1
- 229940093922 Gynecological Antibiotics Drugs 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- DVLFYONBTKHTER-UHFFFAOYSA-N MOPS Chemical compound OS(=O)(=O)CCCN1CCOCC1 DVLFYONBTKHTER-UHFFFAOYSA-N 0.000 description 1
- 229940045184 Malt extract Drugs 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N Ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 101710014781 OGDH Proteins 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- GHSJKUNUIHUPDF-UHFFFAOYSA-N S-(2-Aminoethyl)-L-cysteine Chemical compound NCCSCC(N)C(O)=O GHSJKUNUIHUPDF-UHFFFAOYSA-N 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N Stearic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 229940024982 Topical Antifungal Antibiotics Drugs 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 229940029983 VITAMINS Drugs 0.000 description 1
- 229940021016 Vitamin IV solution additives Drugs 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000005571 anion exchange chromatography Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000340 anti-metabolite Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000002256 antimetabolite Substances 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- 230000003115 biocidal Effects 0.000 description 1
- 230000037348 biosynthesis Effects 0.000 description 1
- 230000001851 biosynthetic Effects 0.000 description 1
- 230000001488 breeding Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000005824 corn Nutrition 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000008246 gaseous mixture Substances 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 229940079866 intestinal antibiotics Drugs 0.000 description 1
- 230000003834 intracellular Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000002503 metabolic Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000000813 microbial Effects 0.000 description 1
- 230000002906 microbiologic Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000006011 modification reaction Methods 0.000 description 1
- QDHHCQZDFGDHMP-UHFFFAOYSA-N monochloramine Chemical compound ClN QDHHCQZDFGDHMP-UHFFFAOYSA-N 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 230000001264 neutralization Effects 0.000 description 1
- 230000000050 nutritive Effects 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 229940005935 ophthalmologic Antibiotics Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229920001522 polyglycol ester Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 238000006268 reductive amination reaction Methods 0.000 description 1
- 230000003252 repetitive Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamins Natural products 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Abstract
Preparation of L-amino acids comprises fermentation of coryneform bacteria in which the nucleotide sequence encoding glutamate dehydrogenase (GDH) is amplified, especially over-expressed.
Description
PROCESS FOR THE PREPARATION BY FERMENTATION OF L-AMINO ACIDS USING CORINEFORM BACTERIA Field of the invention The object of the invention is a process for the preparation by fermentation of L-amino acids using coryneform bacteria, in which the glutamate hydrogenase gene is reinforced. Background of the Invention L-amino acids are used in animal feed in human medicine and in the pharmaceutical industry. The L-amino acids are used by fermentation with strains that produce L-amino acids from coryneform bacteria, especially Corynebacterium glutamicum. Due to the great importance of this group of products, we continuously work to improve these preparation procedures. Process improvements may consist of technical fermentation measures such as agitation and oxygen feed, or the composition of nutritive media such as sugar concentration during fermentation, or post-processing to the form of a product, by means of ion exchange chromatography or by intrinsic properties of microorganisms. To improve the performance properties of these microorganisms, methods such as mutagenesis are used, REF .: 32803 selection and selection of mutants. In this way, strains are obtained which are resistant against antimetabolites, such as, for example, the lysine analogue S- (2-aminoethyl) -cysteine) or auxotrophs for the regulatory amino acids which produce L-amino acids. For several years, methods of DNA recombination technique have been used for the improvement of strains of strains that produce L-amino acids of Corynebacterium glutamicun, in which individual biosynthesis genes are amplified and their effect on the production of the L-amino acids. An article on this is among others that of Konoshita ("Glutamicum Acid Bacteria" in Biology of Industrial Microorganisms, Demain and Solomon (Eds.), Benjamin Cummings, London, UK, 1985, 115-142), Hilliger (BioTec 2, 40-44 (1991)), Jetten and Sunskey (Critical Reviews in Biotechnology 15, 73-.103 (1995)) and Sahm et al., (Annuals of the New York Academy of Science 782, 23-39 (1996)) . The glutamate dehydrogenase enzyme catalyzes the reductive amination of a.-ketoglutaric acid to qutamic acid In French publication 2675492 a DNA fragment of Corynebacterium melassecola 801 carrying a glutamate dehydrogenase gene is described. It is probably used there to increase the production of glutamine acid in the fermentation of Corynebacterium melassecola. The nucleotide sequence of the < glutamate dehydrogenase from Corynebacterium glutamicum ATCC13032 was described by Börmann et al. (Molecular Microbiology 6, 317-326 (1992)). The nucleotide sequence of the glutamate dehydroqenase gene of Peptostreptococcus asaccharolyticus is given by Snedecor et al. (Journal of bacteriology 173, 6162-6167 (1991)). Task of the Invention The inventors set themselves the task of obtaining new measures to improve the preparation by fermentation of other L-amino acids. Detailed Description of the Invention L-amino acids have application in animal feed, human medicine and the pharmaceutical industry. Therefore there is a general interest in a new and improved process for the production of L-amino acids. When L-amino acids are mentioned below, protein-forming amino acids are implicated,
L-lysine, L-threonine, L-isoleucine, L-valine, L-proline, L-tryptophan and eventually its salts and also L-homoserine, especially L-lysine, L-threonine and L-tryptophan. The object of the invention is therefore a process for the preparation by fermentation of L-amino acids using coryneform bacteria which in particular already produce the corresponding L-amino acids and in which the nucleotide sequence encoding the enzyme glutamate hydrogenase is reinforced . Preferred embodiments are found in the claims. The term "booster" describes in this respect the increase in intracellular activity of one or more enzymes in a microorganism, which are encoded by the corresponding DNA, for which, for example, the number of copies of the gene or genes is increased, a strong promoter or a gene that encodes the corresponding enzyme with high activity is used, and these are eventually combined measurements. The microorganisms that are the object of the present invention can produce L-amino acids from glucose, sucrose, lactose, fructose, maltose, melase, starches, cellulose or glycerin and ethanol. It may be a representative of the coryneform bacteria, especially of the genus Corynebacterium. In the genus Corynebacteirum should be mentioned in particular the type Corynebactyerium glutamicum, which are known in the enzyme for its ability to produce L-amino acids. Suitable the genus Corynebacterium especially the type Corynebacterium glutamicum strains are the native type known Corynebacterium glutamicum ATCC13032 Corynebacterium acetoglutamicum ATCC15806 Corynebacterium acetoacidophilum ATCC13870 Corynebacterium thermoaminogenes FERM BP-1539 Brevibacterium flavum ATCCC14067 Brevibacterium lactofermentum ATCC13869 and Brevibacterium divaricatum ATCC14020 strains and mutants or prepared strains such as, for example, the L-lysine producing strains Corynebacterium glutamicum FERM-P 1709 Brevibacterium flavum FERM-P 1708 and Brevibacterium lactofermentum FERM-P 1712, or the strains producing L-threonine Corynebacterium glutamicum FERM-P 5835 Brevibacterium flavum FERM- P 4164 and Brevibacterium lactofermentum FERM-P 4180, or the strains producing L-isoleucine Corynebacterium glutamicum FERM-P 756 Brevibacterium flavum FERM-P 759 and Brevibacterium lactofermentum FERM-P 4192, or strains producing L-valine Brevibacteriu m flavum FERM-P 512 and Brevibacterium lactofermentum FERM-P 1845, or the strains producing L-tryptophan Corynebacterium glutamicum FERM-BP 478 Brevibacterium flavum FERM-P 475 and Brevibacterium lactofermentum FERM-P 7127. From this the inventors found as bacteria After the overexpression of the L-glutamate hydrogenase, they produce L-amino acids in an improved manner, and L-glutaminic acid is not claimed here. The glutamate hydrogenase gene of C. glutamicum described by Börmann et al. (Molecular Microbiology 6, 317-326 (1992)) can be used according to the invention. Furthermore, the glutamate dihydrogenase gene of other microorganisms, such as Peptostptococcus asaccharolytcus, which was described by Snededor et al. (Journal of Bacteriology 173, 6162-6167 (1991)). In addition, the alleles of the mentioned genes can be used, which is obtained by means of the degeneration of the genetic code by means of sense mutations (sense mutations) of neutral function. To obtain the over-expression the number of corresponding copies of the gene can be increased or the promoter and regulatory region, which is upstream of the structural gene, can be imitated. Similarly, the expression cartridges that are built upstream of the structural gene are used. By means of inducible promoters it is additionally possible to increase the expression in the course of pro-fermentation production of L-amino acids. By means of measures to lengthen the life of m-RNA expression is also improved. Furthermore, avoiding the reduction of the enzymatic protein reinforces the enzymatic activity. Genes or genetic constructs can be found in the plasmids with different numbers of copies or be integrated and amplified in the chromosome. Alternatively, an over-expression of the genes in question can be obtained by means of the modification of the composition of the medium and the performance of the culture. Data on this is found by the technician among others in the writings of Martin et al. (Bio / Technology 5, 137-146 (1987)), Guerrero et al. (Gene 138, 35-41 (1994)), Tsychiya and Morinaga (bio / technology 6, 428-430 (1988)) by Eikmanns et al. (Gene 102, 93-98 (1991)), in the European patent document EP 0 472 869, in the patent of US 4,601,893, by Schwarzer and Pühler (bio / technology 9, 84-87 (1991), by Reinscheid et al. Applied and Enviromental Microbiology 60, 126-132 (1994)), in LaBarre et al (Journal of Bacteriology 175, 1001-1007 (1993)), in patent application WO 96/15246, by Jensen and Hammer (Biotechnology and Bioengineering 58, 191-195 (1998)), by Makrides (Microbiological Revies 60: 512-538 (1996)) and in the known texts of Genetics and Molecular Biology Examples of plasmids that can be overexpressed with the help of their glutamate dehydrogenase are pEKl, 0gdh-l and pEKExpgdh, which are found in strains ATCC13032 / pEKl, 9gfdh-l and DH5a / pEKExpgd.The plasmid pEKl, 9gdh-l is a pendulum vector, which contains the glutamate-dependent dihydrogenase gene of glutamate. NADP of C-glutamicum The pELExpgdh plasmid is a pendulum vector containing the NAD-dependent glutamate dehydrogenase gene of Peptostreptoc occus asaccharolyticus. Additionally it may be advantageous for the production of the corresponding L-amino acids, in addition to over-expressing the glutamate dehydrogenase also one or more enzymes of the amino acid biosynthetic pathway in question. For example, • to improve the coryneproducer bacteria producing L-lysine, the coding gene can be overexpressed to dehydrodipicolinate synthase (EP-B 0197335), • to improve the coryneproducer bacteria producing L-valine additionally over-express the coding gene to acetohydroxy acid synthase (EP-B-0356739), • to improve the coryneproducer bacteria producing L-tryptophan additionally over-expressing the coding gene to anthranilic phosphoribosyl transferase (EP-B 0234048), • to improve the L-homoserin or L-threonine-producing coryneform bacteria or L-isoleucine additionally over-express the gene encoding homoserine dehydrogenase (EP-A 0131171). Furthermore, it may be advantageous for the production of the corresponding L-amino acids in addition to the overexpression of glutamate dehydrogenase to avoid unwanted side reactions (Nakayama: "Breeding of Amino Acid Producing Micro-organisms", in: Overpoduction of Microbial Products, Krumphanzl, Sikytam Vanek (eds.); Academic Press, London, UK, 1982), The microorganisms produced according to the invention can be grown continuously or discontinuously in batch processes or in the fed batch or repetitive feeding method.
(repeated fed batch) in order to produce L-amio acids. A summary of known cultivation methods can be found in Chmiel's text (Bioprozestechnik 1. Einführung in die
Bioverfahrenstechnik (Gustav Fischer verlag, Stuttgart, 1991)) or in the text of Storhas (Bioreaktoren und periphere Einrichtungen (Vieweg Verlag, Braunschweig / Wiesbaden, 1994)).
The culture medium used must suitably be sufficient for the requirements of the microorganisms in question. The description of culture media of different microorganisms can be found in the manual "Manual of Methods for General Bacteriology" of the American Society of Bacteriology (Washington D.C., US, 1981). As a carbon source, sugars and carbohydrates can be used, such as glucose, sucrose, lactose, fructose, maltose, melase, starches and cellulose, oils and fats such as soybean oil, sunflower oil, peanut oil and coconut oil. fatty acids such as palmitic acid, stearinic acid and linoleic acid, alcohols such as for example glycerin and ethanol and organic acids such as acetic acid. These substances can be used individually or in mixtures. Nitrogen-containing organic compounds such as peptone, yeast extract, meat extract, malt extract, corn steep water, soybean meal and urea or inorganic compounds such as ammonium sulfate, ammonium chloride, phosphate can be used as nitrogen source. of ammonium, ammonium carbonate and ammonium nitrate. The nitrogen sources can be used alone or as mixtures. Phosphoric acid, potassium dihydrophosphate or dipotassium hydrophosphate or the corresponding sodium-containing salts can be used as phosphorus sources. The culture medium must also contain salts of metals such as magnesium sulfate or iron, which are necessary for growth. Finally, growth promoters such as amino acids and vitamins can be used in addition to the mentioned substances. Suitable pre-stages can be added to the culture medium. The additives mentioned can be added to the culture in the form of a single charge or in a suitable form added during cultivation.
To control the pH of the culture, basic compounds are used, such as sodium hydroxide, potassium hydroxide, ammonia or acidic compounds such as phosphoric acid or sulfuric acid in a suitable form. To control foaming, anti-foaming agents such as fatty acid polyglycol ester or silicone oils can be used. To maintain the stability of the plasmids, selective substances, for example antibiotics, can be added to the medium. To maintain aerobic conditions, oxygen or gaseous mixtures containing oxygen, such as air, are introduced into the culture. The culture temperature is usually at 20 ° C to 45 ° C and preferably at 25 ° C to 40 ° C. The culture is continued until a maximum amount of L-amino acid has been formed. This objective is normally reached in the course of 10 to 160 hours. The analysis of L-amino acids can be performed automatically based on anion exchange chromatography with the subsequent derivation of ninhydrin as described by Spackman et al. (Analytical Chemistry, 30, 1190 (1958)). The following microroganisms were deposited in the German Collection of Microorganisms and Cell Cultures (DSMZ, Braunschweig, Germany) in accordance with the Budapest Treaty:
Strain ATCC13032 (pEKI, 9gdh-l of Corynebacterum glutamicum, as DSM 12614 Strain DH5a / pEKExpgdh of Escherichia coli K12 as DSM 12613. EXAMPLES The present invention will be explained in more detail with the help of the exemplary embodiments. with amino acid producing strains, in which the superiority of the presented procedure is demonstrated: a) The strain of Corynebacterium glutamicum producing L-lysine DSM515, (EP-B-0435 132) and b) the strain of Brevibacterium flavum producing DSM5399 (EP-B-0385940) and c) The strain ATCC13032? IlvA producing L-valine that requires isoleucine, which was deposited as DSM12455 in the Collection German Microorganisms and Cell Cultures in Braunschweig (Germany) in accordance with the Budapest Treaty. Example 1 Preparation of producers of L-amino acids with reinforced glutamate dehydroaenase The plasmid pEK1, 9gfdh-l corresponds to the plasmid described by Börmann et al. (Molecular Microbiology 6, 317-326 (1992)). It was isolated from ATCC13032 / pEK1, Ogdh-1. Similarly, the known plasmid pEKExpgdh (Marx et al., Metabolic Engineering 1, 35-48 (1999)), which carries the glutamate dehydrogenase gene of Peptostreptococcus asaccharolyticus (Snedecor et al., Journal of Bacteriology 173, 6162-6167). (1991)), was isolated from the E. coli strain DH5a / pEKExpgdh. Strains DSM5715, DSM5399 and ATCC13032? IlvA were transformed as described by Leibl et al. (Fems Microbiology letters 65, 299-304 (1989)) with the plasmid pekl, 9gdh-l. The selection of the transformants was carried out on a brain-heart agar from Merck
(Darmstadt, Germany) with was supplemented with 50 mg / l. In this way the strains DSM5715 / Pekl, 9gdh-l were formed,
DSM5399 / pEKl, 9gdh-l and ATCC13032? LLVa / Pekl, 9gdh-l. In the same way, strain DSM5715 was transformed with plasmid pEKExpgdh and strain DSM5715 / pEKExpgdh was obtained. Example 2 Preparation of L-lysine The strain DSM5715 / Pekl, 9gdh-1 was precultured in a 2TY complex medium consisting of 16 g / 1 Trypton, 10 g / 1 yeast extract and 5 g / 1 NaCl. For this, 60 ml of 2TY medium were added, which were obtained in a 500 ml Erlenmeyer flask with 2 mouths, inoculated with one unit of the strain and the culture was cultured for 12 hours at 150 rpm, and 30 ° C. To inoculate 60 ml of the production medium, which was obtained in the 500 ml Erlenmeyer flask with 2 nozzles, the preculture was centrifuged at 5000 rpm in a Sepatech Minifuge RF centrifuge (Heraeus, Hanau, Germany) for 10 minutes. The cream was discarded and the pellet was resuspended in 1 ml of production medium. An aliquot of this cell suspension was added to the production medium, in such a way that an OD600 of approx. 2.0. The CGXII medium described by Keilhauer et al. Was used as the production medium. (Journal of Bacteriology 175, 5595-5603 (1993)) with pH 7.0 (Table 1) supplemented with 20 g / 1 glucose, 350 mg / l leucine and 50 mg / l kanamycin monosulfate. The cultures were incubated for 72 hours at 30 ° C and 150 rpm. Table 1
The optical densities (OD) (Biochrom Novaspec 4049, LKB Instrument GmbH, Gräfing, Germany) were then determined at a measured wavelength of 600 nm and the concentration of L-lysine formed with an amino acid analyzer from Eppenmdorf. -BioTronik (Hamburg, Germany) by means of ion exchange chromatography and post-column reaction with detection of hybridine. Table 2 shows the results of this test. Table 2
Example 3 Preparation of L-threonine and L-isoleucine Strain DSM5399 / pEK1, 9gdh-1 was pre-cultured in complete medium CglII (Kase &Nakayama, Agricultural and Biological Chemistry 36 (9) 1611-1621 (1972) with 50 μg / ml kanamycin 10 ml of CglII medium was inoculated, which was obtained in the 100 ml Erlenmeyer flask with 4 nozzles with one unit of the strain and the culture was incubated for 16 hours at 240 rpm and 30 ° C. To inoculate 10 ml of production medium that was obtained in the 100 ml Erlenmeyer flask with 4 nozzles, the OD (660 n) of the preculture was determined.The main culture was inoculated at an OD of 0.1. used the CgXII medium described by Keilhauer et al.,
(Journal of Bacteriology 1993, 175: 5595-5603). The composition of the medium is represented in example 2. 4% glucose and 50 mg / l of kanamycin sulfate were added.
The cells were incubated at 33 ° C, 250 rpm and 80% humidity in the air for 48 hours. The optical densities were then determined at 660 nm and the concentration of L-threonine and L-isoleucine formed as described in Example 2. The results of these tests are given in Table 3.
Table 3
EXAMPLE 4 Preparation of L-valine Strain ATCC13032? IlvA / pEKI, 9gdh-1 was precultured in complete medium CglII (Kase &Nakayama, Agricultural and Biological Chemistry 36 (9) 1611-1621 (1972)) with 50 μg / ml Kanamycin For this, 50 ml of CglII medium was inoculated, which was obtained in the 500 ml Erlenmeyer flask with 4 nozzles with one unit of the strain and the culture was incubated for 16 hours at 140 rpm and 30 ° C. To inoculate 60 ml of production medium that was obtained in the 500 ml Erlenmeyer flask with 4 mouths, the OD (660 n) of the preculture was determined. The main culture was centrifuged and the residue was discarded. The pellet was taken in 5 ml of production medium and the main culture was inoculated to an OD of 0.3. The CgXII medium described by Keilhauer et al. Was used as the production medium,
(Journal of Bacteriology 1993, 175: 5595-5603) as described in example 3 (with 4% glucose). The composition of the medium is represented in example 2. The cells were incubated at 30 ° C, 150 rpm for 48 hours. Next, the optical densities at 660 nm and the concentration of L-valine formed as described in example 2 were determined. Table 4 gives the results of those tests. Table 4
E p e 4 Preparation of L-lysine, L-valine and L-alanine Strain DSM5715 / pEKExpgdh was precultured in a complex 2TY medium consisting of 16 g / 1 Trypton, 10 g / 1 yeast extract and 5 g / 1 of NaCl. For this, 60 ml of 2TY medium were added, which were obtained in a 500 ml Erlenmeyer flask with 2 mouths, inoculated with one unit of the strain and the culture was cultured for 12 hours at 150 rpm, and 30 ° C. To inoculate 60 ml of the production medium, which was obtained in the 500 ml Erlenmeyer flask with 2 nozzles, the preculture was centrifuged at 5000 rpm in a Sepatech Minifuge RF centrifuge (Heraeus, Hanau, Germany) for 10 minutes. The cream was discarded and the pellet was resuspended "in 1 ml of production medium, an aliquot of this cell suspension was added to the production medium, in such a way that an OD600 of 0.4 was obtained. the CGC medium described by Schrumpf et al (Journal of Bacteriology 173, 4510-4516 (1991)) (Table 5) supplemented with 25 g / 1 glucose, 350 mg / l leucine and 52 g / 1 3-morpholinopropanesulfonic acid and 50 mg / l of kanamycin sulfate at a pH of 7. The cultures were incubated for 30 hours at 30 ° and 150 rpm.
The optical densities (OD) were then determined (Biochrom Novaspec 4049, LKB Instrument GmbH, Gráfeling, Germany) at a measured wavelength of 600 nm and the concentration of L-alanine, L-lysine and L-valine formed with a amino acid analyzer from the firm Eppenmdorf-BioTronik (Hamburg, Germany) by means of ion exchange chromatography and post-column reaction with detection of hybridine. Table 6 gives the results of this test. Table 6
It is clear that the best method known to the applicant to carry out the aforementioned invention is that which is clear from the present description of the invention.
Claims (6)
- CLAIMS Having described the invention as above, property is claimed as contained in the following:
- Procedure for the preparation of L-amino acids by means of the fermentation of coryneform bacteria, characterized in that bacteria are used in which the nucleotide sequence coding for glutamate dehydrogenase is reinforced, in particular it is over-expressed. 2. Process according to claim 1, characterized in that the glutamate hydrogenase produced in the bacteria used depends on NADP.
- 3. Method according to claim 1, characterized in that the glutamate hydrogenase produced in the bacteria used depends on NAD.
- 4. Method according to claim 1, characterized in that bacteria are used in which the other genes of the metabolic pathway of the formation of the desired L-amino acids are additionally strengthened.
- 5. Process according to claim 1, characterized in that bacteria are used in which the metabolic pathways that reduce the formation of the desired L-amino acids are at least partially deactivated.
- 6. - Method according to one or more of the preceding claims, characterized in that a strain transformed with a plasmid vector is used and the plasmid vector carries the nucleotide sequence coding for glutamate dihydrogenase. 1 . - Process according to claim 6, characterized in that bacteria transformed with the plasmid vector pEK1, 9gdh-1 deposited in Corynebacterium glutamicum under the number DSM 12614 are used. 8. Method according to claim 6, characterized in that they are used bacteria transformed with the plasmid vector pEKExpgdh deposited in E. coli under the number DSM 12613. 9. - Process for the preparation by fermentation of L-amino acids according to one or more of the preceding claims, characterized in that the following steps are carried out a) fermentation of the L-amino acid producing bacteria in which at least the glutamate dihydrogenase gene is reinforced, b) increase of the desired L-amino acids in the medium or in the cells of the bacteria and c) isolated from the L-amino acids. 10. Method according to one or more of the preceding claims, characterized by using coryneform bacteria that produce one or more of the amino acids L-lysine, L-threonine, L-isoleucine, L-valine, L-proline, L -triptofano and L-homoserina.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19907347.3 | 1999-02-20 | ||
US09324940 | 1999-06-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA00001638A true MXPA00001638A (en) | 2002-06-05 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU770187B2 (en) | Process for the fermentative production of L-amino Acids using coryneform bacteria | |
US6355454B1 (en) | Process for the fermentative production of L-amino acids using coryneform bacteria | |
US20040253628A1 (en) | Alleles of the lysC gene from corynebacteria | |
SK10202000A3 (en) | L-lysine producing coryneform bacteria and method for the production of l-lysine | |
CA2321975A1 (en) | Nucleotide sequences coding for the export of branched-chain amino acids, process for the isolation thereof and use thereof | |
US20030199045A1 (en) | Process for the preparation of L-amino acids with amplification of the zwf gene | |
US20090117624A1 (en) | Process for the fermentative preparation of organic chemical compounds using coryneform bacteria in which the SugR gene is present in attenuated form | |
US20030175911A1 (en) | Process for the preparation of L-amino acids with amplification of the zwf gene | |
US7759056B2 (en) | Nucleotide sequence encoding the dapC gene and process for the production of L-lysine | |
AU2236900A (en) | Process for the production of L-amino acids by fermentation using coryeform | |
US6379934B1 (en) | Process for the fermentative preparation of L-amino acids using coryneform bacteria | |
US20020028490A1 (en) | Process for the production of L-amino acids by fermentation using coryneform bacteria | |
US20050079588A1 (en) | Method for the fermentative production of L-amino acids, using coryneform bacteria | |
US20030109014A1 (en) | Process for the fermentative preparation of L-amino acids with amplification of the tkt gene | |
EP1709166A1 (en) | Process for the preparation of l-amino acids with amplification of the zwf gene | |
SK16692000A3 (en) | Process for the fermentative preparation of l-lysine by using coryneform bacteria | |
EP1077261A2 (en) | A process for the fermentative preparation of metabolic products and for the nucleotide sequences encoding sod | |
MXPA00001638A (en) | Process for the fermentative production of l-amino acids using coryneform bacteria | |
MXPA00004870A (en) | Process for the fermentative preparation of l-amino acids using coryneform bacteria | |
MXPA00002332A (en) | Process for the fermentative preparation of l-amino acids using coryneform bacteria | |
EP1361278A2 (en) | Process for the production of amino acids using phosphoglucose isomerases from coryneform bacteria |